French pharma company's acquisition of pre-clinical stage biotech includes mRNA-based research platform
Company also raised full year manufacturing capacity target for vaccine to 2.5 billion doses
Deal could be worth over $700m including potential future milestone payments
AZD7442 is a long-acting antibody combination that could help to prevent and treat COVID-19
Swiss pharma company will gain respiratory pathogen panels to strengthen its COVID-19 testing capabilities
Five Prime's pipeline includes potentially first-in-class anti-FGFR2b antibody bemarituzumab
Company can acquire asset following the completion of IND enabling studies
Company has signed agreements to bolster vaccine manufacturing capacity
Development and commercialisation deal could be worth up to $1.08bn
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
As Moderna expects COVID-19 vaccine sales to reach $18.4bn this year
Merck will gain a pipeline of immune modulators targeting autoimmune diseases
Company announced clinical hold on gene therapy earlier this month after suspected serious adverse reaction
US government will pay $1.95bn for additional 100 million doses
Sandoz, the generics division of Novartis, will pay $350m upfront for three established brands
Most recent quarter is first 'for many years' in which product sales were in excess of $7bn
Pfizer/BioNTech's has an existing agreement with the EU for an initial 300 million doses
The latest movers in pharma
The latest movers in pharma and biotech
Latest movers in pharma and biotech
Latest movers in pharma
The latest industry movers
imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...